JournoLink uses cookies JournoLink requires cookies to function. You can read more in our Privacy Policy

Enzymedica UK

Enzymedica Develops Supplement for Digesting Fatty Foods

25 April 2016 05:30


Lypo Gold aims to relieve discomfort from fatty foods through enzyme supplementation. Enzymedica, The Enzyme Expert company, has developed Lypo Gold, an enzyme supplement that relieves digestive discomfort caused by eating fatty foods. Each individual capsule of this new enzyme supplement helps consumers optimize fat digestion by digesting up to 22 grams of fat. (Research organization SRQ Bio concluded these findings.)

For those who experience digestive difficultly such as flatulence, bloating or nausea when eating fatty foods like sausages, pork pies and bacon, Lypo Gold offers a natural way to continue eating these foods. “Lypo Gold is simply a better way to enjoy the foods you love without discomfort,” said Tom Bohager, founder and chairman of Enzymedica. “Whether it’s a full English breakfast, bacon butties, meat pies or chips, fat is a part of most of our regular diets. Additionally, Lypo Gold ensures that healthy fats, such as those found in salmon and other oily fish, avocados, coconut oil and olive oil are doing their job as effectively as possible to provide us with the energy we need on a daily basis."

Supplementing a diet with digestive enzymes, such as the unique lipase blend found in Lypo Gold, can be helpful as the human body’s natural digestive enzymes start to decline with age. Foods that previously caused no issue to digest when we were younger often become problematic as we get over 30 years of age. Enzymedica’s exclusive Thera-blend process, which involves blending enzyme strands together, produces potent and effective digestive products to help with these digestive problems.

In addition to supporting fat digestion, Lypo Gold can also offer cardiovascular and cholesterol support and is a useful tool for the 50,000 people who have their gallbladders removed each year (, 2015). Post-surgery there is no longer an organ to store bile, which helps to break down fatty foods, and it is estimated that more than half of these patients have difficultly digesting fat.
Lypo Gold is now available in the UK at and in selected independent Health Food stores.

To find out more contact:
Susan Warris-Liepa
High Res image of Lypo Gold available upon request.

Download as PDF | Report this press release

Attached Images

Press Contacts

Carole Petch

PR Manager

Tel: 0845 528 1296


About Enzymedica UK

For over 20 years Enzymedica has been researching, creating and producing exclusive blends of plant-based digestive enzymes for digestive health and food intolerances. With exceptional quality and purity utilized at point of manufacture, Enzymedica is dedicated to providing enzyme-focused supplements at the most therapeutic levels available in the natural foods industry. Enzymedica’s unique, patented TheraBlend ™ and TherActive™ delivery technologies allow for up to 6 x faster absorption in the digestive system. All Enzymedica products provide immediate bioavailability, have absolutely no fillers, and are 100% vegetarian.

Enzymedica’s enzyme formulas lead the industry in quality and efficacy, and have a line of award winning products that have been honored by both retailers and consumers. Digest™ and Digest Gold™ are the two top selling digestive enzymes on the USA market place, according to SPINS, a market research and consulting firm for the Natural Products Industry.

Enzymes do so much more than relieve the symptoms often associated with digestive distress such as heartburn, indigestion and bloating. They are the foundation to good health and have been called the “spark of life”. Enzymedica believes that knowledge has the power to change lives and is committed to providing education and research that propels individuals on the path to vibrant health. On-line training modules are available for retail owners and staff members. Digestive health questions will be answered by the Enzymedica team of health experts.

Dedicated to digestive health worldwide, Enzymedica provides financial support and educational outreach to the autism community and beyond. In 2009 Tom Bohager, Founder & CEO of Enzymedica, founded the Autism Hope Alliance (AHA), a nonprofit organisation dedicated to raising funds for autism awareness and treatment.

TMC Ventures Europe Ltd. is proud to be the exclusive distributor for Enzymedica UK & Eire. TMC Ventures is an importing and distribution company that focuses on innovative, interesting and differentiated products - making a healthy difference in the lives of their customers.

TMC Ventures provides a boutique management and consulting service to American Brands that wish to gain market presence in the UK and Europe.

View JournoLink Profile


Share to Facebook Share to Twitter Share to LinkedIn


For more information on JournoLink and how to receive more content like this, please visit